ASX Announcements

Keyword Search

2013 | 2012 | 2011 | 2010 | 2009

Date	Title
05/17/13	HeartWare to Webcast Presentation at UBS Global Healthcare Conference
05/10/13	ASX Appendix 3B - Options vesting and exercise
05/07/13	First Quarter 2013 Financial Results
04/30/13	Reports 2013 Q1 Rev of US$49.2M vs US$26.4M in Q1 2012
04/22/13	ASX Appendix 3B - Options Vesting, Exercise and Cancellation
04/16/13	Notice of Annual General Meeting
04/02/13	ASX Appendix 3B - Options Exercise
03/27/13	ASX Appendix 3B - Options Vesting and Exercise
03/21/13	Change of Director's Interest Notice
03/19/13	HeartWare International, Inc. Announces Closing of Public Offering of Common Stock
03/19/13	Options Exercise - ASX Appendix 3B
03/19/13	Capital Raising - ASX Appendix 3B Allotment
03/19/13	Capital Raising - Cleansing Notice
03/15/13	ASX Appendix 3B - Options Exercise
03/15/13	Prospectus Supplement for Public Offering of Common Stock
03/14/13	Prospectus for Public Offering of HeartWare Common Stock
03/13/13	Pricing of Public Offering of Common Stock
03/12/13	HeartWare Announces Public Offering of Common Stock
03/11/13	ASX Appendix 3B - Grant and Cancellation of Options
03/11/13	ASX Appendix 3B - Options Grant
03/07/13	HeartWare to Webcast Presentation at Barclays Capital Global
03/01/13	HeartWare to Webcast Presentation at Raymond James Conference
02/28/13	Annual Report for 2012 and ASX Appendix 4E
02/28/13	Reports 2012 Revenue of US$110.9M vs US$82.8M in 2011
02/19/13	Notice of Fourth Quarter Financial Results Call
02/18/13	Grant of Incentive Equity - ASX Appendix 3B
02/11/13	HeartWare to webcast presentation at Leerink Swann Global Healthcare Conference to be webcast
02/11/13	HeartWare Initiates Voluntary Field Correction Advising Insp
01/23/13	Amended Change of Director's Interest Notice
01/22/13	Change of Director's Interest Notice
01/16/13	ASX Appendix 3B
01/10/13	ASX Appendix 3B - Grant and Cancellation of Options
01/08/13	HeartWare Announces Preliminary Q4 2012 Revenues of US$32Mil
01/04/13	HeartWare to Webcast Presentation at JP Morgan Healthcare Co
01/04/13	Amended Change of Director's Interest Notice
01/02/13	ASX Appendix 3B - Options Exercise and Vesting
01/02/13	Change of Director's Interest Notice
12/21/12	ASX Appendix 3B - Options Exercise
12/21/12	Change of Director's Interest Notice
12/17/12	Change of Director's Interest Notice
12/12/12	Options Exercise and Vesting - ASX Appendix 3B
12/06/12	HeartWare to Webcast Presentation at Oppenheimer Healthcare
12/06/12	Change of Director's Interest Notice
12/06/12	ASX Appendix 3B - Options Exercise and Cancellation
11/27/12	Options Vesting, Exercise and Expiration - ASX Appendix 3B
11/27/12	Change of Director's Interest Notice
11/21/12	HeartWare Receives U.S. FDA Approval For HVAD Pump
11/20/12	HeartWare to Webcast Presentation at Piper Jaffray Healthcare
11/16/12	Supplemental Financial Information for Q1 2012
11/12/12	HeartWare to Webcast Presentation at Lazard Healthcare Conference
11/12/12	Third Quarter 2012 Financial Results
11/12/12	Reports 2012 Q3 Rev of US$ 22.9 M vs. US$ 21.3 M in 2011 Q3
11/02/12	Notice of Third Quarter Financial Results Call
10/23/12	Option Exercise - ASX Appendix 3B
10/16/12	HeartWare to Withdraw Participation in Pilot Study Revive-It
09/28/12	ASX Appendix 3B - Options Exercise and Options Cancellation
09/26/12	ASX Appendix 3B - Options Grant
09/24/12	ASX Appendix 3B - Options Exercise
09/24/12	Change of Director's Interest Notice
09/17/12	HeartWare to Webcast Presentation at UBS Global Life Science
09/03/12	Options Exercise - ASX Appendix 3B
09/03/12	Change of Director's Interest Notice
08/28/12	Change of Director's Interest Notice
08/22/12	Change of Director's Interest Notice
08/10/12	HeartWare to Webcast Presentation at Wedbush PacGrow Lifesciences
08/09/12	Appendix 4D and Half Year Financial Statement
08/08/12	ASX Appendix 3B - Consideration for World Heart Acquisition
08/08/12	Reports 2012 Q2 Rev of US$29.1 M vs US$20.4 M in 2011 Q2
08/07/12	Change of Director's Interest Notice
08/07/12	ASX Appendix 3B - Options Exercise
08/03/12	HeartWare Completes Acquisition of World Heart Corp
07/31/12	Notice of Second Quarter Financial Results Call
07/20/12	Option Exercise - ASX Appendix 3B
07/19/12	Change of Director's Interest Notice
07/17/12	Change of Director's Interest Notice
07/10/12	HeartWare Names Peter McAree Chief Financial Officer
07/06/12	ASX Appendix 3B - Options Exercise and Forfeiture
07/06/12	Change of Director's Interest Notice
07/06/12	Change of Director's Interest Notice
06/27/12	ASX Appendix 3B - Options Exercise
06/20/12	Change of Director's Interest Notice
06/19/12	Option Exercise - ASX Appendix 3B
06/15/12	ASX Appendix 3B - Options Exercise
06/15/12	Change of Director`s Interest Notice
06/13/12	Grant of Incentive Equity - ASX Appendix 3B
06/13/12	HeartWare Names New Company Secretary
06/12/12	Change of Director`s Interest Notice
06/07/12	ASX Appendix 3B - Options Exercise and Forfeiture
06/06/12	Change of Director`s Interest x 8
06/06/12	ASX Appendix 3Z - Final Director`s Interest Notice
06/01/12	Annual General Meeting Results
06/01/12	Annual General Meeting Materials
05/29/12	Change of Director`s Interest Notice
05/25/12	ASX Appendix 3B - Options Exercise, Vesting and Cancellation
05/24/12	HeartWare Announces Publication of Data from U.S. Bridge to Transplant Clinical Trial
05/24/12	HeartWare Receives CE Mark Addendum For Label Expansion
05/23/12	Change of Director`s Interest Notice
05/22/12	Change of Director`s Interest Notice
05/22/12	Change of Director`s Interest
05/22/12	Change of Director`s Interest Notice
05/15/12	Change of Director`s Interest Notice
05/15/12	Change of Director`s Interest x 7
05/11/12	Reports 2012 Q1 Rev of US$26.3 M vs US$18.0M in Q1 of 2011
05/08/12	HeartWare to Webcast Presentation at Bank of America Health
05/04/12	Notice of First Quarter Financial Results Call
05/01/12	Option Exercise - ASX Appendix 3B
05/01/12	Change of Director`s Interest Notice
05/01/12	Change of Director`s Interest Notice
04/30/12	Notice of Annual General Meeting
04/26/12	HeartWare Receives Favorable US FDA Panel Vote
04/03/12	ASX Appendix 3B - Options Vesting, Exercise and Cancellation
03/30/12	HeartWare Enters Agreement to Acquire WorldHeart for US$8M
03/26/12	ASX Appendix 3B - Options Grant and Cancellation
03/19/12	ASX Appendix 3B - Options vesting, exercise and cancellation
03/19/12	HeartWare Receives New CAP Allotment from FDA for Bridge to
03/14/12	Change of Director`s Interest Notice
03/07/12	Change of Director`s Interest Notice
03/07/12	HeartWare to Webcast Presentation at Barclays Global Healthc
03/06/12	HeartWare Presentation At The Barclays Capital 2012 Global Healthcare Conference To Be Webcast
03/06/12	Initial Director`s Interest Notice
03/02/12	Change of Director`s Interest Notice
03/02/12	Change of Director`s Interest Notice
02/28/12	Annual Report for 2011 and ASX Appendix 4E
02/27/12	Change of Director`s Interest Notice
02/20/12	Change of Director`s Interest Notice
02/17/12	Reports Q4 Rev of US$23.1M and Annual 2011 Rev of US$82.8M
02/15/12	HeartWare Announces Date for FDA Advisory Committee Panel
02/07/12	Notice of Fourth Quarter Financial Results Call
02/02/12	Change of Director`s Interest Notice
01/10/12	Q4 2011 Preliminary Revenue and JPM Conference
01/10/12	HeartWare and Dualis Announce Development Agreement
01/09/12	Change of Director`s Interest Notice
12/28/11	Grant of Incentive Equity - ASX Appendix 3B
12/28/11	ASX Appendix 3B - Options Exercise
12/28/11	Change of Director`s Interest Notice
12/15/11	Option Exercise - ASX Appendix 3B
12/15/11	Change of Director`s Interest Notice
12/12/11	HeartWare to Present at Oppenheimer Healthcare Conference
12/06/11	Appendix 3B - Options Exercise
12/06/11	Change of Director`s Interest Notice
12/05/11	Amended Change of Director`s Interest Notice
11/25/11	ASX Appendix 3B - Options Exercise
11/24/11	HeartWare to Present at Piper Jaffray Health Care Conference
11/18/11	Change of Director`s Interest Notice
11/14/11	ASX Appendix 3B - Options Exercise
11/11/11	HeartWare to Present at Lazard Capital Markets Healthcare Co
11/04/11	Third Quarter 2011 Financial Results
10/28/11	HeartWare Announces Third Quarter Revenues of US$21.3 M
10/28/11	HeartWare Announces Planned Departure of CFO
10/24/11	Notice of Third Quarter Financial Results Call
10/20/11	Grant of Incentive Equity - ASX Appendix 3B
10/10/11	Change of Director`s Interest Notice
10/03/11	Presentation of Clinical Update for BTT and CAP at EACTS
10/03/11	HeartWare Announces Updated Clinical Data Presented at EACTS
09/29/11	HeartWare to Present Clinical Update at 25th EACTS in Lisbon
09/22/11	ASX Appendix 3B - Options Exercise and Vesting
09/21/11	Change of Director`s Interest Notice
09/20/11	HeartWare to Present at Lazard Capital Circulatory Assist Co
09/15/11	HeartWare to Present at UBS Global Life Sciences Conference
09/14/11	Change of Director`s Interest Notice
09/12/11	Preclinical Data for Next Generation MVAD Pump Presented
09/12/11	Slide Presentation of MVAD Preclinical Data at ISRBP
09/12/11	Change of Director`s Interest Notice
09/08/11	Change of Director`s Interest Notice
08/26/11	Change of Director`s Interest Notice
08/24/11	Options Grant - ASX Appendix 3B
08/24/11	ASX Appendix 3B - Options Exercise
08/15/11	HeartWare to Present at Wedbush Securities 2011 Health Care
08/09/11	HeartWare to Present at Canaccord Genuity 31st Annual Growth
08/08/11	Appendix 4D and Half Year Financial Statement
08/08/11	ASX Appendix 3B - Option Exercise and Vesting
08/05/11	Reports Second Quarter 2011 Revenues of US$20.4 Million
08/03/11	Change of Director`s Interest Notice
07/28/11	Second Quarter Financial Results Call
06/28/11	Reimbursement Approval in France
06/28/11	Initiation of pre-arranged trading plan
06/28/11	Options Exercise - ASX Appendix 3B
06/28/11	ASX Appendix 3B - Option Grant
06/28/11	Change of Director`s Interest Notice
06/23/11	Webcast slides (with clinical update) from Wells Fargo 2011
06/17/11	HeartWare to present at Wells Fargo 2011 Healthcare Conference
05/27/11	ASX Appendix 3B - Option Exercise
05/23/11	Change of Director`s Interest Notice
05/20/11	Change of Director`s Interest Notice
05/20/11	Change of Director`s Interest Notice
05/17/11	Change of Director`s Interest Notice
05/17/11	Grant of Incentive Equity - Appendix 3B
05/13/11	Annual General Meeting Results
05/12/11	Annual General Meeting Materials
05/09/11	First Quarter 2011 Financial Results
05/09/11	Change of Director`s Interest
05/09/11	HeartWare to Present at Bank of America Merrill Lynch Health
05/09/11	ASX Appendix 3B - Option Exercise and Vesting
05/06/11	Reports First Quarter 2011 Revenues of US$18 Million
04/27/11	First Quarter Financial Results Call
04/27/11	HeartWare Supplemental Addendum to CE Mark Accepted by BSI
04/18/11	Presentation of BTT and CAP data at ISHLT 2011
04/18/11	HeartWare BTT and CAP data presented at ISHLT 2011
04/13/11	Announces ISHLT presentations, 1,000 global implants
04/11/11	Notice of Annual General Meeting
03/25/11	HeartWare receives approval from TGA in Australia
03/18/11	U.S. FDA accepts HeartWare PMA filing for review
03/17/11	Option Exercise - ASX Appendix 3B
03/09/11	Exercise of Stock Options - ASX Appendix 3B
03/03/11	Option Grant - ASX Appendix 3B
03/01/11	Change of Director`s Interest Notice
02/28/11	Annual Report for 2010 and ASX Appendix 4E
02/16/11	Fourth Quarter Earnings Release Call
01/28/11	Amended Change of Director`s Interest Notice
01/27/11	Option Exercise - ASX Appendix 3B
01/27/11	Change of Director's Interest Notice
01/25/11	HeartWare Named to REVIVE IT Heart Failure Study
01/24/11	FDA Grants HeartWare 94-Patient Allotment for BTT CAP
01/18/11	Option Exercise - ASX Appendix 3B
01/11/11	Q4 2010 Preliminary Revenue and JPM Conference
01/06/11	Option Exercise - ASX Appendix 3B
01/05/11	HeartWare to present at JP Morgan Healthcare Conference
12/29/10	HeartWare Submits PMA to FDA for Bridge-to-Transplant
12/23/10	Change of Director`s Notice
12/23/10	Annual Employee Equity Allocation / Appendix 3B
12/21/10	HeartWare Insider Trading Policy
12/16/10	Completion of Concurrent Public Offerings
12/16/10	ASX Appendix 3B - HeartWare Converible Notes
12/16/10	Change in Director's Interest Notice
12/16/10	Prospectus Public Offering of Common Stock and Convertible N
12/14/10	HeartWare Announces Pricing of Concurrent Public Offerings
12/09/10	HeartWare International, Inc. Announces Concurrent Public Offerings of Convertible Senior Notes and Common Stock
11/24/10	Option Exercise - Appendix 3B
11/19/10	HeartWare to present at annual Piper Jaffray Health Conference
11/15/10	HeartWare Bridge-to-Transplant Data Announcement
11/15/10	ADVANCE trial data presentation at AHA 2010
11/12/10	HeartWare to present at Lazard Annual Healthcare Conference
11/10/10	Clinical Trial Data at AHA, Investor meeting webcast
11/05/10	Third Quarter 2010 Financial Statements
11/04/10	Third Quarter Results
10/21/10	Third Quarter Earnings Release Call
09/28/10	Option Exercise - ASX Appendix 3B
09/23/10	Change of Director`s Interest Notice
09/06/10	Option Exercise - ASX Appendix 3B
09/06/10	FDA Grants HeartWare Second Patient Allotment Under CAP
08/19/10	Option Grant - ASX Appendix 3B
08/19/10	Option Exercise - ASX Appendix 3B
08/12/10	HeartWare Study to be Late-Breaker at American Heart Assn.
08/09/10	Appendix 4D and Half Year Financial Statements (US GAAP)
08/06/10	HeartWare Announces Second Quarter Results
08/05/10	HeartWare to Present at Canaccord Growth Conference
07/30/10	HeartWare to Present at Wedbush Best Ideas Conference
07/28/10	Second Quarter Earnings Release Call
07/07/10	Amended ASX Appendix 3Bs
07/02/10	Option Exercise - ASX Appendix 3B
07/02/10	Option Grant - ASX Appendix 3B
06/25/10	Announces Board Succession
06/18/10	HeartWare to present at Wells Fargo
06/18/10	Exercise of Options - ASX Appendix 3B
06/15/10	HeartWare To Commence Destination Therapy Trial
06/07/10	Exercise and Cancellation of Options
05/07/10	Change of Director`s Interest Notices
05/05/10	Annual General Meeting Results
05/05/10	Grant of Incentive Equity - Appendix 3B
05/05/10	Annual General Meeting Materials
05/05/10	Appendix 3B
05/05/10	First Quarter 2010 Financial Statements
05/04/10	First Quarter Results
05/03/10	Appendix 3B
04/27/10	Initiates voluntary repairs and recalls certain controllers
04/27/10	First 100 Patient Commercial and Clinical Data
04/12/10	Heartware to Report Financial Results First Quarter of 2010
04/12/10	Notice of Annual General Meeting
04/08/10	FDA Approves Continued Access Protocol for BTT
03/26/10	Amended ASX Appendix 3B
03/24/10	Change of Director`s Interest Notice
03/24/10	Appendix 3B - Exercise of Stock Options
03/05/10	HeartWare to Present at Annual Roth Growth Conference
03/03/10	Grant and Cancellation of Equity - ASX Appendix 3B
03/03/10	Change of Director's Interest Notice
03/03/10	Appendix 3B - Vesting of Preformance Rights
02/24/10	Annual Report for 2009 and ASX Appendix 4E
02/23/10	Reports Q4 Rev. of US$12.2M and Annual Rev. of US$24.2M
02/23/10	Enrollment of US Bridge to Transplant Trial Completed
02/09/10	Fourth Quarter and Annual Results for 2009 Earnings Call
02/03/10	Completion of US$62 million Capital Raising
02/03/10	Capital Raising - Cleansing Notice
02/03/10	Capital Raising - ASX Appendix 3B Allotment
02/01/10	Exercise and Cancellation of Options
01/28/10	Pricing of Public Offering of Common Stock
01/27/10	Prospectus for Public Offering of HeartWare Common Stock
01/27/10	Public Offering of HeartWare Common Stock
01/12/10	Shareholder Update
01/04/10	Thoratec Loan Facility Update
12/10/09	Exercise of Options - Appendix 3B
12/08/09	Change of Director's Interest Notice
12/02/09	Exercise of Expiring Incentive Options
11/24/09	HeartWare files IDE for Destination Therapy
11/23/09	Change of Director's Interest Notice
11/23/09	Exercise of (Expiring) Options
11/17/09	Change of Director`s Interest Notices
11/17/09	Exercise of Options - ASX Appendix 3B
11/10/09	Change of Contact Details for HeartWare
11/09/09	CEO Presenting at Investment Conferences
11/06/09	HeartWare to Present at Upcoming Investment Conferences in November
11/05/09	Revenues of US$7.5M for Quarter Ended 30 September 2009
11/05/09	Financial Statements for September 30, 2009
10/29/09	Advance Notice of Q3 Earnings Call
10/27/09	Capital Raising Allotment - ASX Appendix 3B
10/27/09	Stockholder Meeting Results - Capital Raising Approved
10/27/09	Cleansing Notice for Capital Raising
10/06/09	FDA Approves Expansion to 40 Sites for US BTT Trial
10/05/09	Exercise of Incentive Options
09/23/09	Notice of Special Meeting of Stockholders - Capital Raising
09/21/09	Annual Employee Equity Allocation
09/21/09	Exercise and Cancellation of Options
09/07/09	Option Exercise and Cancellations
09/02/09	Reinstatement to Official Quotation
09/02/09	Half Yearly Report / Accounts and Review Report
08/21/09	HeartWare Surpasses 50 US Implants
08/18/09	Cleansing Notice for US$60 Miliion Placement
08/18/09	Closes US$60 Million Placement
08/17/09	ASX Appendix 4D And Half Year Financial Statements (US GAAP)
08/11/09	US$55 Million Capital Raising
08/03/09	Joint Termination of Merger
07/31/09	Change of Directors Interests - Annual Meeting Stock Issue
07/31/09	Issue of Stock Pursuant to Annual Meeting Approval
07/31/09	Quarterly Update And ASX Appendix 4C
07/30/09	Annual Meeting Results
07/30/09	US FTC to Challenge Thoratec Acquisition of HeartWare
07/30/09	Trading Halt
07/30/09	Annual Meeting Materials
07/29/09	Annual Meeting to be Webcast
07/21/09	Change of Interests in Securities for Executive Director
07/06/09	Appendix 3B - Vesting of RSUs
07/02/09	Appendix 3B
06/18/09	Appendix 3B
06/17/09	Revised Thoratec Merger Documentation
06/12/09	Notice of Annual General Meeting/Proxy Form
05/12/09	CEO Presenting at JMP Securities Research Conference
05/12/09	Quarterly Financial Statements 31 March 2009
05/11/09	Thoratec Files Registration Statement
05/08/09	Thoratec Files Registration Statement
04/30/09	Quarterly Update April 2009 and ASX Appendix 4C
04/24/09	European Clinical Data Update
03/31/09	First International Sales of HeartWare® Ventricular Assist System and US Clinical Trial Enrolment Update
03/27/09	Thoratec and HeartWare Receive Request for Additional Information from US. Federal Trade Commission
03/18/09	Appendix 3B
02/27/09	2008 Annual Financial Report
02/27/09	2008 Preliminary Final Report
02/20/09	NASDAQ Listing Confirmation
02/19/09	HeartWare to be Acquired By Thoratec Corporation for US$282
02/18/09	Additional Merger Documentation
02/16/09	HeartWare to be Acquired By Thoratec Corporation for US$282
02/13/09	Trading Halt
02/10/09	First Implants at Northwestern Memorial
02/06/09	Co-PI Appointed for US Clinical Trial
01/30/09	Quarterly Report and CEO Letter
01/30/09	CE Mark Approval received
01/13/09	J P Morgan Healthcare Conference Presentation
12/31/08	Cancellation of Options
12/17/08	Principal Investigator Appointed for US Clinical Trial
12/05/08	Enrollment of International Trial Completed
12/04/08	NASDAQ Dual Listing Filing
11/20/08	MVAD & HVAD Update
11/20/08	2nd US Clinical Site Commences Implants
11/18/08	CEO Healthcare Conference Presentations
11/07/08	Initial Directors Interest Notice
11/05/08	HeartWare Group Redomiciliation and Trading of CDIs
11/03/08	Date of Allotment of CDI Securities
11/03/08	Indicative Top 20 Holders
11/03/08	Admission to the Official List
11/03/08	Lodgement of Court Orders with ASIC
10/31/08	Quarterly Update And ASX Appendix 4C
10/30/08	Federal Court Approval of Schemes of Arrangement
10/24/08	Cleveland Clinic Presentation
10/22/08	Redomiciliation Meeting Materials
10/22/08	Redomiciliation Meeting Results
10/20/08	Awarded ISO Certification
10/15/08	Medical Conference Presentations
10/03/08	Non-Executive Director Appointed
10/03/08	Initial Directors Interest Notice
09/25/08	Cancellation of Options
09/23/08	FDA Grants Full IDE Approval in the United States
09/22/08	Redomiciliation Documents Dispatched to Shareholders
09/17/08	Federal Court Approval for Scheme Meetings for Redomiciliation
09/15/08	Change of Directors Interests
09/11/08	CE Mark Submission
09/08/08	Change of Directors Interest
09/04/08	Change of Share Registry
09/03/08	Cancellation of Options
09/03/08	Change of Directors Interests
09/03/08	Change of Directors Interests
08/28/08	Change of Directors Interests
08/27/08	Change of Directors Interests
08/26/08	Change of Directors Interests
08/25/08	Change of Directors Interests
08/22/08	Change of Directors Interests
08/21/08	First U.S. Implant
08/19/08	Change of Directors Interests
08/14/08	Annual Equity Award
08/14/08	Change of Directors Interests
08/13/08	Half-Year Financial Report 30 June 2008
08/12/08	Canaccord Adams Presentation
08/12/08	Canaccord Adams Presentation
08/12/08	Canaccord Adams Presentation
08/05/08	Proposed Redomiciliation in the United States
08/01/08	First IRB Approval in the United States
07/31/08	Quarterly Update and Appendix 4C
07/25/08	Redemption of Convertible Note
07/11/08	Change of Directors Interests - Placement
07/11/08	Grant of Options to Non Executive Director
07/11/08	Completion of Placement A$31M
07/11/08	Results of EGM
07/11/08	EGM Materials
06/20/08	Cancellation of Options
06/11/08	SPP Cancelled
06/04/08	Notice of Extraordinary General Meeting
05/27/08	Shareholder Share Purchase Plan Update
05/26/08	Preliminary Notice of Meeting - EGM
05/23/08	Private Placement in Excess of A$30 Million
05/16/08	Operational Update
05/09/08	2008 Annual General Meeting
05/09/08	Results of Annual General Meeting 2008
05/09/08	Grant of Performance Rights
05/09/08	Change of Directors Interest
05/08/08	Change of Directors Interests
05/06/08	Change of Directors Interests
05/05/08	FDA grants conditional IDE approval
05/02/08	Change of Directors Interest
04/30/08	Non-Executive Director Appointed
04/30/08	Quarterly Update And ASX Appendix 4C
04/29/08	Chief Medical Officer Appointe
04/18/08	New Manufacturing Facility
04/18/08	2007 Annual Report
04/14/08	Clinical Data for First 23 Patients
04/14/08	Clinical Data for First 23 Patients
04/09/08	Notice of Annual General Meeting 2008
03/26/08	Draft Notice of Annual General Meeting 2008
03/26/08	Cancellation of Employee Share Options
03/04/08	30th Patient - Survival Update
02/29/08	2007 ASX Appendix 4E - Preliminary Final Report
02/29/08	2007 Annual Financial Report And Directors Report
02/29/08	2007 US Annual Report (US GAAP)
02/06/08	Change of Directors Interest
02/05/08	Change of Directors Interest
01/31/08	Quarterly Update & 4C
01/27/08	Incentive Option Terms for Non-Exec.Directors & Inteq Ltd
12/19/07	Shareholder Update
12/13/07	Appendix 3B - ESOP
12/04/07	Change of Address of Share Registry
11/20/07	Performance Rights and ESOP Grant
11/20/07	Appendix 3B - ESOP
11/20/07	Appendix 3B - Incentive Options
11/02/07	Presentation at ISRBP Conference
11/01/07	Submission to FDA for Investigational Device Exemption (IDE)
10/31/07	Quarterly Update And ASX Appendix 4C
09/03/07	Completion of Enrolment in International Clinical Trial
08/31/07	Interim Financial Report 30 June 2007
08/21/07	Change of Directors Interest
08/15/07	US GAAP Financial Statements - Quarter Ended 30 June 2007
08/07/07	Participant Bulletin
07/31/07	Quarterly Update And ASX Appendix 4C
07/26/07	EGM Presentation Materials
07/26/07	Results of EGM
07/26/07	Private Placement Complete
07/26/07	Change of Directors Interest
07/26/07	Grant of Options Under ESOP
07/26/07	Change of Directors Interest
07/26/07	Change of Directors Interest
07/24/07	First Recovery Patient
07/24/07	Share Purchase Plan Closed
07/19/07	Dual Reporting Requirements
07/17/07	Updated Registration Statement on Form 10 - US GAAP Financials
07/13/07	Clinical Trial Update - July 2007
07/10/07	Change of Address
07/04/07	Change of Directors' Interest
07/03/07	Change of Directors Interest
06/27/07	Notice of EGM
06/26/07	Share Purchase Plan
06/14/07	Private Placement in Excess of $30 Million
05/24/07	Annual General Meeting Confirmation
05/23/07	Annual General Meeting Materials
05/23/07	Results of Annual General Meeting
05/01/07	HeartWare Moves Towards NASDAQ Listing
04/30/07	Quarterly Update And ASX Appendix 4C
04/20/07	Annual Report & Notice of AGM
04/20/07	Cancellation of ESOP Options
04/11/07	First Implant at St Vincent's
04/03/07	Ethics Committee Approval at St Vincent's Hospital
04/02/07	Fourth Implant Centre Opened
03/22/07	One Year Anniversary of First Implant
03/13/07	Shareholder Update
03/13/07	CEO Presentation
02/28/07	ASX Appendix 4E 31 December 2006
02/28/07	2006 Annual Financial Report and Directors' Report
01/31/07	Quarterly Update & ASX Appendix 4C
01/18/07	End of Restriction Period
01/18/07	Appendix 3B - Exercise of ESOP Options
01/10/07	First Implant at Hannover Medical Centre
01/03/07	Grant of Options under ESOP
01/03/07	Letter to Shareholders
01/03/07	Change of Directors Interest
12/11/06	Appointment of Non Executive Director
11/29/06	CEO Presentation November 2006
11/29/06	Change of Directors Interests
11/22/06	Executive Appointment & 5th Implant
11/20/06	Change of Directors Interest
11/06/06	Change of Directors Interest
10/31/06	Quarterly Report
10/31/06	Appointment of Executive Director
10/31/06	Grant of Options
10/23/06	First Implant at Royal Perth
10/23/06	ASX Appendix 3B
10/18/06	Change of Directors Interest
10/11/06	Letter to Shareholders
10/10/06	Change of Directors Interest
10/10/06	Change of Directors Interest
10/04/06	Appendix 3B
10/03/06	Change of Directors Interest
09/14/06	Change of Directors Interest
09/04/06	Appointment of New Chief Executive Officer
07/31/06	2006 Interim Financial Report
07/31/06	Quarterly Cash Flow June 2006
07/26/06	ESOP Grant
07/07/06	German Regulatory Approval
07/06/06	Clarification of Option Cancellation
07/05/06	ASX Appendix 3B
06/20/06	Change of Directors Interest
06/19/06	Change of Directors Interest
06/16/06	Change of Directors Interest
06/16/06	Closing of HeartWare SPP
06/15/06	Presentation at the Australian Biotechnology Expo
06/13/06	Change of Directors Interest
05/23/06	2006 Annual General Meeting Presentation
05/23/06	Annual General Meeting Results
05/23/06	Completion of Capital Raising
05/22/06	Regulatory Approval in the United Kingdom
05/19/06	HeartWare Shareholder Share Purchase Plan
05/15/06	Change of Directors Interest
05/11/06	Change of Directors Interest
05/10/06	$32.5 Million Capital Raising
04/28/06	Clinical Trial Update - April 2006
04/21/06	Chief Operating Officer Appointed
04/20/06	Annual Report 2005 and Notice of Annual General Meeting
04/20/06	ASX Appendix 4C Quarter Ended 31 March 2006
03/27/06	Annual Financial Report and Directors Report 31 Dec 2005
03/24/06	Clinical Trials Commence
03/15/06	Change of Directors Interests
03/08/06	TGA Approval
02/28/06	ASX Appendix 4E
01/31/06	ASX Appendix 4C 31 December 2005
01/30/06	Removal of FORUS
01/24/06	Amended Director Interests
01/10/06	End of Restriction Period
01/05/06	Regulatory Approval
01/03/06	Initial Substantial Shareholder Notice
12/15/05	Appendix 3B
12/01/05	Change of Directors Interest
12/01/05	ASX Appendix 3B
11/10/05	Settlement of Patent Dispute
11/02/05	Completion of Studies
10/19/05	Negotiations Commence
10/19/05	Quarterly Cash Flow
10/11/05	Advisory Board GLP Review
09/27/05	Change of Directors Interest
09/09/05	New Medical Advisory Board Appointee
09/06/05	Ventracor Litigation Announcement
09/06/05	Change of Address
08/31/05	MVAD
08/16/05	CEO Presentation
08/02/05	Defence and Counterclaim to Litigation
08/01/05	GLP Update
07/29/05	BIVAD Implant
07/25/05	Half Year Report
07/25/05	ASX Appendix 4C
07/22/05	Shareholder Update
07/01/05	Change of Directors Interest
07/01/05	Appendix 3B
05/27/05	Change of Director's Interest Notice
05/23/05	Appendix 3B - Exercise of Options
05/03/05	New Executive Appointments & Appendix 3B
03/17/05	VCR release re claims on VCR's ASX announcement platform
03/16/05	Shareholder Update
03/10/05	Change of Director's Interest Notice
03/04/05	Appointment of Chief Financial Officer
03/04/05	Change of Director's Interest Notice
02/22/05	Change of Director's Interest Notice
02/15/05	Change of Director's Interest Notice
02/10/05	Granted first European Patent
02/08/05	Change of Director's Interest Notice
02/08/05	Amended Appendix 3X - Initial Director's Interest Notice
02/07/05	Change of Director's Interest Notice x2
02/02/05	Change of Director's Interest Notice x2
02/01/05	Initial Director's Interest Notice x5
01/28/05	Correction to Admission to Official List-Issue Price Amended
01/27/05	Constitution
01/27/05	Appendix 1A - ASX Listing Application & Agreement
01/27/05	Convertible Note Terms
01/27/05	Employee Share Option Plan
01/27/05	Statement of Commitments
01/27/05	Top 20 Holders
01/27/05	Escrow Statement
01/27/05	Distribution Schedule
01/27/05	Company's Letter to Australian Stock Exchange
01/27/05	Pre-Quotation Disclosure
01/27/05	Admission to Official List
01/27/05	Circular to Participating Organisations - Regulation S
01/27/05	Circular re Commencement of Official Quotation
01/17/05	Disclosure Document
12/17/04	Prospectus